Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses and Other Current Liabilities

v3.20.1
Accrued Expenses and Other Current Liabilities
3 Months Ended
Mar. 31, 2020
Accrued Expenses and Other Current Liabilities  
Accrued Expenses and Other Current Liabilities

Note 7. Accrued Expenses and Other Current Liabilities

Accrued expenses consist of the following:

 

 

 

 

 

 

 

 

    

March 31, 2020

    

December 31, 2019

 

 

 

 

 

Drugs and clinical trial expenses

 

$

2,118

 

$

1,215

Accrued salaries, benefits and travel related costs

 

 

663

 

 

1,570

Professional and consultant fees

 

 

277

 

 

126

Legal expenses

 

 

450

 

 

140

Other administrative accruals

 

 

92

 

 

69

 

 

$

3,600

 

$

3,120

 

 

Other current liabilities as of March 31, 2020 includes $192 for the current portion of Operating lease liabilities and $1,740 for the financing of insurance premiums.